首页> 外文期刊>International Journal of Pharmacological Research >Effect of omega-3 fatty acids versus 5-hydroxytryptophan as add on therapy to sertraline in controlling suicidal ideation in patients with depression: A comparative study
【24h】

Effect of omega-3 fatty acids versus 5-hydroxytryptophan as add on therapy to sertraline in controlling suicidal ideation in patients with depression: A comparative study

机译:欧米伽3脂肪酸与5-羟色氨酸的联合应用对舍曲林治疗抑郁症患者自杀意念的疗效比较研究

获取原文
           

摘要

Background: Omega-3 fatty acids and 5-hydroxytryptophan have been gaining attention as promising alternative treatment for depressive illness. These agents are given as as add on treatment to conventional antidepressant drugs. The present study was carried out to evaluate efficacy of omega-3 fatty acids versus 5-hydroxytryptophan as add on therapy in controlling suicidal ideation in depressive patients on sertraline. Methods: This was a prospective, open label, randomized, parallel group study conducted in department of Psychiatry. Ninety treatment na?ve patients (18-65 years age) were divided into 3 groups of 30 each. Group I: Sertraline, Group II: Sertraline plus omega-3 fatty acids, Group III: Sertraline plus 5-hydroxytryptophan. Suicidal ideations were assessed with Beck’s scale for suicidal ideation (BSI) at weeks 0, 4 and 8. Data were analyzed using repeated measures ANOVA (SPSS version 20.0). Post hoc analysis was done using Bonferroni test. Results: Baseline parameters in patients of all groups were comparable. Administration of sertraline resulted in reduction of Beck’s scale for suicidal ideation scores as compared to baseline. Addition of omega-3 fatty acids and 5-hydroxytryptophan also showed reduction in BSI scores. Effect of sertraline monotherapy was more as compared to omega-3 fatty acids or 5-hydroxytryptophan as add on therapy, which was statistically significant (p value < 0.05). Conclusion: Both omega-3 fatty acids and 5-hydroxytryptophan produce significant effect in controlling suicidal ideations in patients with depression.
机译:背景:ω-3脂肪酸和5-羟色氨酸已成为人们关注的有希望的抑郁症替代疗法。这些药物是对常规抗抑郁药的补充治疗。进行本研究以评估omega-3脂肪酸与5-羟色氨酸在控制舍曲林抑郁症患者中控制自杀意念方面的疗效。方法:这是在精神病学部门进行的前瞻性,开放标签,随机,平行分组研究。将90名初次接受治疗的患者(18-65岁)分为3组,每组30名。第一组:舍曲林,第二组:舍曲林加omega-3脂肪酸,第三组:舍曲林加5-羟色氨酸。在0、4和8周时用Beck的自杀意念(BSI)量表评估自杀意念。使用重复测量ANOVA(SPSS 20.0版)分析数据。使用Bonferroni检验进行事后分析。结果:所有组患者的基线参数均具有可比性。与基线相比,舍曲林的使用导致Beck自杀意念得分的量表降低。 ω-3脂肪酸和5-羟色氨酸的添加也表明BSI分数降低。与omega-3脂肪酸或5-羟色氨酸相比,舍曲林单一疗法的疗效更高,具有统计学意义(p值<0.05)。结论:omega-3脂肪酸和5-羟色氨酸均能有效控制抑郁症患者的自杀意念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号